(4-24)-ply(a) and Arthritis--Rheumatoid

(4-24)-ply(a) has been researched along with Arthritis--Rheumatoid* in 1 studies

Reviews

1 review(s) available for (4-24)-ply(a) and Arthritis--Rheumatoid

ArticleYear
Targeting nanomedicines in the treatment of rheumatoid arthritis: focus on certolizumab pegol.
    International journal of nanomedicine, 2007, Volume: 2, Issue:1

    Anti-TNFalpha therapy has revolutionized the treatment of rheumatoid arthritis (RA) and other inflammatory diseases. These drugs are powerful and expensive. A new anti-TNFalpha agent, a nanomolecule comprising a humanized Fab' antibody fragment against TNFalpha with a polyethylene glycol tail, is shortly to complete phase III trials in RA. In this review we will discuss the construct of this new molecule, data from trials so far, and its potential place in the market place.

    Topics: Antibodies, Monoclonal, Humanized; Antimicrobial Cationic Peptides; Antirheumatic Agents; Arthritis, Rheumatoid; Certolizumab Pegol; Clinical Trials as Topic; Drug Carriers; Drug Delivery Systems; Humans; Immunoglobulin Fab Fragments; Nanomedicine; Polyethylene Glycols

2007